These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 11565854)

  • 1. Research strategies for design and development of NSAIDs: clue to balance potency and toxicity of acetanilide compounds.
    Pal AK; Sen S; Ghosh S; Bera AK; Bhattacharya S; Chakraborty S; Banerjee A
    J Biomol Struct Dyn; 2001 Aug; 19(1):85-93. PubMed ID: 11565854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the nonsteroidal anti-inflammatory drug literature for potential developmental toxicity in rats and rabbits.
    Cook JC; Jacobson CF; Gao F; Tassinari MS; Hurtt ME; DeSesso JM
    Birth Defects Res B Dev Reprod Toxicol; 2003 Feb; 68(1):5-26. PubMed ID: 12852480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents.
    Kurumbail RG; Stevens AM; Gierse JK; McDonald JJ; Stegeman RA; Pak JY; Gildehaus D; Miyashiro JM; Penning TD; Seibert K; Isakson PC; Stallings WC
    Nature; 1996 Dec 19-26; 384(6610):644-8. PubMed ID: 8967954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamics and pharmacokinetics of nonsteroidal anti-inflammatory drugs in species of veterinary interest.
    Lees P; Landoni MF; Giraudel J; Toutain PL
    J Vet Pharmacol Ther; 2004 Dec; 27(6):479-90. PubMed ID: 15601442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preferential COX-2 inhibition: its clinical relevance for gastrointestinal non-steroidal anti-inflammatory rheumatic drug toxicity].
    Dammann HG
    Z Gastroenterol; 1999 Jan; 37(1):45-58. PubMed ID: 10091284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis of the anti-inflammatory activity of melatonin.
    de la Rocha N; Rotelli A; Aguilar CF; Pelzer L
    Arzneimittelforschung; 2007; 57(12):782-6. PubMed ID: 18380411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A free energy based computational pathway from chemical templates to lead compounds: a case study of COX-2 inhibitors.
    Latha N; Jain T; Sharma P; Jayaram B
    J Biomol Struct Dyn; 2004 Jun; 21(6):791-804. PubMed ID: 15107001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, biological evaluation, and comparative Cox1 and Cox2 docking of p-substituted benzylidenamino phenyl esters of ibuprofenic and mefenamic acids.
    Hegazy GH; Ali HI
    Bioorg Med Chem; 2012 Feb; 20(3):1259-70. PubMed ID: 22225915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays.
    Riendeau D; Charleson S; Cromlish W; Mancini JA; Wong E; Guay J
    Can J Physiol Pharmacol; 1997 Sep; 75(9):1088-95. PubMed ID: 9365818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nonsteroidal anti-inflammatory drugs. Declaration I. A study of interrelation "structure--the effectiveness of anti-inflammatory action"].
    Khaĭrullina VR; Mukhametov AD; Tiurina LA; Garifullina GG; Gerchikov AIa; Zarudiĭ FS
    Biomed Khim; 2007; 53(3):266-75. PubMed ID: 17722576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesis.
    Sengupta S; Sellers LA; Cindrova T; Skepper J; Gherardi E; Sasisekharan R; Fan TP
    Cancer Res; 2003 Dec; 63(23):8351-9. PubMed ID: 14678996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New NSAIDS: COX-1, COX-2, what about them?].
    Peretz A
    Rev Med Brux; 1998 Sep; 19(4):A399-402. PubMed ID: 9805982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between cyclooxygenase 1 and 2 selective inhibitors and fetal development when administered to rats and rabbits during the sensitive periods for heart development and midline closure.
    Cappon GD; Cook JC; Hurtt ME
    Birth Defects Res B Dev Reprod Toxicol; 2003 Feb; 68(1):47-56. PubMed ID: 12852483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and biological evaluation of 6-substituted-3-(4-methanesulfonylphenyl)-4-phenylpyran-2-ones: a novel class of diarylheterocyclic selective cyclooxygenase-2 inhibitors.
    Praveen Rao PN; Amini M; Li H; Habeeb AG; Knaus EE
    J Med Chem; 2003 Nov; 46(23):4872-82. PubMed ID: 14584938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic basis for selective inhibition of cyclo-oxygenases.
    Gierse JK; Koboldt CM; Walker MC; Seibert K; Isakson PC
    Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):607-14. PubMed ID: 10215599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and use of iodinated nonsteroidal antiinflammatory drug analogs as crystallographic probes of the prostaglandin H2 synthase cyclooxygenase active site.
    Loll PJ; Picot D; Ekabo O; Garavito RM
    Biochemistry; 1996 Jun; 35(23):7330-40. PubMed ID: 8652509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theoretical studies on the inhibition mechanism of cyclooxygenase-2. Is there a unique recognition site?
    Soliva R; Almansa C; Kalko SG; Luque FJ; Orozco M
    J Med Chem; 2003 Apr; 46(8):1372-82. PubMed ID: 12672237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Non-steroidal anti-inflammatory agents (NSAID's) with lesser side effects by selective inhibition of cyclo-oxygenase-2].
    Bijlsma JW; Van de Putte LB
    Ned Tijdschr Geneeskd; 1998 Aug; 142(31):1762-5. PubMed ID: 9856140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: what can we expect?
    Geis GS
    Scand J Rheumatol Suppl; 1999; 109():31-7. PubMed ID: 10422544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemistry of prostaglandin endoperoxide H synthase-1 and synthase-2 and their differential susceptibility to nonsteroidal anti-inflammatory drugs.
    Smith WL; DeWitt DL
    Semin Nephrol; 1995 May; 15(3):179-94. PubMed ID: 7631045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.